Oellerich, T., Schneider, C., Thomas, D., Knecht, K. M., Buzovetsky, O., Kaderali, L., . . . Cinatl, J. (2019). Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. Nature Portfolio.
Chicago Style (17th ed.) CitationOellerich, Thomas, et al. Selective Inactivation of Hypomethylating Agents by SAMHD1 Provides a Rationale for Therapeutic Stratification in AML. Nature Portfolio, 2019.
MLA (8th ed.) CitationOellerich, Thomas, et al. Selective Inactivation of Hypomethylating Agents by SAMHD1 Provides a Rationale for Therapeutic Stratification in AML. Nature Portfolio, 2019.
Warning: These citations may not always be 100% accurate.